Rapamycin Holdings, Inc. — Form D/A

Rapamycin Holdings, Inc. of SAN ANTONIO, TX, a company, filed a Form D amendment with the SEC on 2014-02-03. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2014-02-03
• Form: D/A
• Accession: 0001582949-14-000001
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $1.4M
• Amount sold: $1.4M
• Minimum investment: $44K
• Investors: 18
• Date of first sale: 2013-07-16
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-200510

Issuer

• Name: Rapamycin Holdings, Inc.
• CIK: 0001582949
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2012
• Address: 16601 BLANCO RD. SUITE #120, SAN ANTONIO, TX, 78232
• Phone: 210-381-2486

Officers, directors & promoters (8)

Other filings by this issuer (6)

More

• CIK 1582949 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search